Sleep disorders, associated with anxiety and depressive disorders, and their corrections peculiarities in the oncogynecological practice

  • G. Vasylyeva Donetsk National Medical University of the Ministry of Health of Ukraine
Keywords: insomnia, anxiety, depression, patients suffering from reproductive organs’ malignant neoplasms

Abstract

30–75 % of patients with visualized forms of malignant tumors suffer from sleep disorders, which are comorbid with anxiety and depressive disorders. With the purpose of detection and correction of sleep disorders associated with anxiety-depressive disorders in patients with malignant neoplasms of the female reproductive system we study an emotional condition of 210 patients with reproductive organs’ malignant tumors. Insomnia disorders were detected in (72.4 ± 3.1) % patients suffering from reproductive organs’ malignant neoplasms. According to the ICD-10, emotional disorders accompanied by insomnia were presented by anxious and depressive disorders within symptomatic anxiety disorder (11.4 % ± 2.2 %), symptomatic depressive disorder (31.0 % ± 3.2 %), and adjustment disorder with prolonged depressive reaction (5.2 % ± 1.5 %), mixed anxiety and depressive reaction (11.4 % ± 2.2 %) and prevalence of anxiety reactions (13.3 % ± 2.3 %). In the structure of insomnia in patients suffering from malignant neoplasms presented presomnic (79.5 % ± 2.8 %), intrasomnic (40.9 % ± 3.2 %) and postsomnic disturbances (27.1 % ± 2.6 %). In our research we revealed a combination of pre-, intra- and postsomnic disturbances (47.3± 4.6 %). According to the Insomnia Severity Index the severity of insomnia in cancer patients was higher in the structure of symptomatic anxiety and depressive disorders than in the structure of adaptive disorders. After 4 weeks complex treatment a significant decrease in the severity of insomnia, depression and anxiety noted. In-time diagnosis and correction of insomniac disorders associated with anxiety-depressive disorders in cancer patients is a prerequisite for the success of specific antitumor treatment, improving the quality and duration of their lives.

Downloads

Download data is not yet available.

References

1. Belanger L. Management of hypnotic dyscontinuation in chronic insomnia // Sleep. Med. Clin. – 2009. – Vol. 4. – P. 583–592.

2. Berger A. M., Parker K. P., Young-McCaughan S. et al. Sleep wake disturbances in people with can- cer and their caregivers: state of the science // Oncol. Nurs. Forum. – 2005. – Vol. 32, N 6. – P. 98–126.

3. Davidson J. R., Maclean A. W., Brundage M. D., Schultze K. Sleep disturbances in cancer pa- tients // Soc. Set. Med. – 2002. – Vol. 54. – P. 1309–1321.

4. Fortner B. V., Stepanski E. J., Wang S. C. et al. Sleep and quality of life in breast cancer patients // J. Pain Symptom Manage. – 2002. – Vol. 24. – P. 471–480.

5. Savard M.-H., Savard J., Simard S., Ivers H. Empirical Validation of the Insomnia Severity Index in Cancer Patients // Psycho-Oncology. – 2005. – Vol. 14. – P. 429–441.

6. Snaith R. P. The Hospital Anxiety and Depression Scale // Health and Quality of Life Out- comes. – 2003. – Vol. 1. – P. 29.

7. Tariq S. H., Pulisetty S. Pharmacotherapy in insomnia // Clin. Geriatr. Med. – 2008. – Vol. 24, N 1. – P. 93–105.

8. Zisapel N. The use of melatonin for the treatment of insomnia // Biol. Signals Recept. – 1999. – Vol. 8, N 1–2. – P. 84–89.

Abstract views: 84
PDF Downloads: 59
Published
2017-09-30
How to Cite
Vasylyeva, G. (2017). Sleep disorders, associated with anxiety and depressive disorders, and their corrections peculiarities in the oncogynecological practice. Likars’ka Sprava, (5-6), 108-112. https://doi.org/10.31640/LS-2017(5-6)18
Section
Guide lines for the practitioner